MediKarma Launches Healthcare’s First “Agentic AI” Licensing Model

Why It Matters

By turning AI agents into licensable infrastructure, MediKarma enables rapid, data‑driven care delivery and measurable cost reductions across the fragmented health ecosystem.

Key Takeaways

• Jack AI ingests full lifetime EMR data in 120 seconds.
• Validated health score correlates 90.6% with risk reduction.
• Jill AI drives 35% MAU, 40% improvement over baseline.
• Licensing model promises $700‑$3,185 cost savings per member.
• Partners can deploy disease‑specific agents like Diabetes Jill instantly.

Pulse Analysis

The healthcare industry has long wrestled with data silos that impede real‑time decision‑making. MediKarma’s Jack AI tackles this challenge by offering a universal EMR ingestion engine capable of aggregating a patient’s entire medical history in just two minutes. This speed, combined with a FICO‑style health score validated against millions of claims, gives insurers and providers a single source of truth for risk stratification, a capability previously reserved for tech giants with massive data warehouses.

Beyond data aggregation, the company’s Jill AI suite introduces autonomous, disease‑specific engagement agents that act like virtual health coaches. Early studies show Diabetes & Obesity Jill achieving 35% monthly active users—four times the industry norm—and delivering over 40% improvement on clinical baselines. Such engagement translates directly into higher adherence, lower readmission rates, and ultimately, the $700‑$3,185 per‑member cost reductions that health plans are eager to capture. By licensing these agents, organizations can embed proven AI expertise without the overhead of in‑house development.

MediKarma’s licensing model reframes AI from a product to a utility layer, akin to an operating system for health tech. This “Intel Inside” approach lowers barriers to entry for smaller health plans and employers, democratizing access to advanced analytics and personalized care pathways. As the market shifts toward value‑based reimbursement, the ability to instantly fuse claims, clinical notes, and wearable data into actionable insights will become a competitive differentiator, positioning MediKarma as a foundational infrastructure partner in the next wave of digital health transformation.